Health Care & Life Sciences » Pharmaceuticals | Guangdong Jiaying Pharmaceutical Co. Ltd.

Guangdong Jiaying Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
139,490.50
73,653.90
66,354.90
55,172.00
214,761.70
35,878.60
Depreciation, Depletion & Amortization
14,884.70
23,462.10
21,354.70
25,700.10
27,233.60
27,389.40
Other Funds
8,435.50
7,333.60
-
1,405.10
1,587.40
4,915
Funds from Operations
44,396.00
99,891.90
83,974.60
83,642.40
57,853.00
68,129.80
Changes in Working Capital
21,073.30
1,271.10
43,747.90
30,515.60
27,221.10
6,027.10
Net Operating Cash Flow
23,322.60
101,163.00
40,226.70
53,126.90
30,631.90
62,102.70
Capital Expenditures
8,716.80
98,741.50
33,420.70
11,980.90
18,438.50
Sale of Fixed Assets & Businesses
-
0.40
1,020.20
76.80
2,475.70
Purchase/Sale of Investments
-
8,750.00
9,000.00
2,500.00
4,250.00
Net Investing Cash Flow
28,413.50
123,247.50
23,400.50
14,404.00
20,212.80
Cash Dividends Paid - Total
6,150.00
19,965.00
-
-
20,300.00
Issuance/Reduction of Debt, Net
3,550.00
19,000.00
3,900.00
10,200.00
20,100.00
Net Financing Cash Flow
18,135.50
8,298.60
3,900.00
11,605.10
1,787.40
Net Change in Cash
33,600.50
30,383.10
12,926.20
27,117.70
8,631.80
Free Cash Flow
14,605.80
2,421.50
6,806.00
41,146.00
12,193.40
Deferred Taxes & Investment Tax Credit
32,633.00
554.40
2,307.20
1,535.60
260.70
53.20
Other Sources
37,130.20
243.60
-
-
-
Other Uses
-
16,000.00
-
-
-

About Guangdong Jiaying Pharmaceutical Co.

View Profile
Address
Dongsheng Industrial Park
Meizhou Guangdong 514021
China
Employees -
Website http://www.gdjyzy.com.cn
Updated 07/08/2019
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the manufacture, sale, research and development of Chinese traditional medicine. It manufactures variety of drugs, mainly for the treatment of throat, cold, orthopedic and rheumatoid diseases. The company was founded on March 7, 2003 and is headquartered in Meizhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.